7-65388858-G-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_152626.4(ZNF92):c.183G>T(p.Glu61Asp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000342 in 1,433,666 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_152626.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ZNF92 | NM_152626.4 | c.183G>T | p.Glu61Asp | missense_variant | 3/4 | ENST00000328747.12 | NP_689839.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ZNF92 | ENST00000328747.12 | c.183G>T | p.Glu61Asp | missense_variant | 3/4 | 1 | NM_152626.4 | ENSP00000332595 | P2 | |
ZNF92 | ENST00000450302.2 | c.-25G>T | 5_prime_UTR_variant | 2/3 | 1 | ENSP00000396126 | ||||
ZNF92 | ENST00000357512.3 | c.130+830G>T | intron_variant | 1 | ENSP00000350113 | A2 | ||||
ZNF92 | ENST00000431504.1 | c.-2-9483G>T | intron_variant | 1 | ENSP00000400495 |
Frequencies
GnomAD3 genomes AF: 0.00 AC: 7AN: 149072Hom.: 0 Cov.: 32 FAILED QC
GnomAD3 exomes AF: 0.0000199 AC: 5AN: 250746Hom.: 0 AF XY: 0.0000295 AC XY: 4AN XY: 135564
GnomAD4 exome AF: 0.0000342 AC: 49AN: 1433666Hom.: 1 Cov.: 30 AF XY: 0.0000280 AC XY: 20AN XY: 713094
GnomAD4 genome Data not reliable, filtered out with message: AS_VQSR AF: 0.0000469 AC: 7AN: 149190Hom.: 0 Cov.: 32 AF XY: 0.0000549 AC XY: 4AN XY: 72802
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jan 26, 2022 | The c.183G>T (p.E61D) alteration is located in exon 3 (coding exon 3) of the ZNF92 gene. This alteration results from a G to T substitution at nucleotide position 183, causing the glutamic acid (E) at amino acid position 61 to be replaced by an aspartic acid (D). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at